ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 264 filers reported holding ALKERMES PLC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,217,429 | -49.6% | 1,252,953 | -54.6% | 0.17% | -56.4% |
| Q1 2023 | $77,864,980 | +12.8% | 2,762,149 | +4.6% | 0.38% | -9.0% |
| Q4 2022 | $69,024,381 | +26.8% | 2,641,576 | +8.4% | 0.42% | +21.0% |
| Q3 2022 | $54,421,000 | -6.6% | 2,437,137 | +24.6% | 0.35% | -1.1% |
| Q2 2022 | $58,255,000 | -14.0% | 1,955,507 | -24.0% | 0.35% | -0.3% |
| Q1 2022 | $67,709,000 | -1.8% | 2,573,524 | -13.2% | 0.35% | -1.7% |
| Q4 2021 | $68,961,000 | -12.5% | 2,964,792 | +16.0% | 0.36% | -16.1% |
| Q3 2021 | $78,795,000 | +19.1% | 2,554,976 | -5.3% | 0.43% | +14.4% |
| Q2 2021 | $66,131,000 | +29291.6% | 2,696,997 | +69446.1% | 0.37% | +7380.0% |
| Q1 2018 | $225,000 | -75.8% | 3,878 | -77.2% | 0.01% | -79.2% |
| Q4 2017 | $930,000 | – | 16,996 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |